Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1046/j.1442-200x.2002.01632.x

http://scihub22266oqcxt.onion/10.1046/j.1442-200x.2002.01632.x
suck pdf from google scholar
12421268!ä!12421268

suck abstract from ncbi


Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid12421268      Pediatr+Int 2002 ; 44 (6): 670-4
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Nitric oxide further attenuates pulmonary hypertension in magnesium-treated piglets #MMPMID12421268
  • Haas KM; Suzuki S; Yamaguchi N; Kato I; Ban K; Tanaka T; Fukuda S; Togari H
  • Pediatr Int 2002[Dec]; 44 (6): 670-4 PMID12421268show ga
  • BACKGROUND: Persistent pulmonary hypertension of the newborn (PPHN) commonly appears as a complication of several pulmonary and non-pulmonary diseases. The hypoxia possibly inhibits Ca2+ +/- dependent K+ channels, thus resulting in membrane depolarization of pulmonary smooth muscle cells, which leads to the opening of Ca2+ channels and Ca2+ entry, resulting in contraction of the vascular smooth muscle. However, magnesium (Mg2+) is an antagonist of Ca2+. We studied the effect of magnesium sulfate on the treatment of hypoxia-induced pulmonary hypertension and compared to the site of action of nitric oxide (NO). METHODS: Zero-day-old piglets were used in each experiment. The effects of Mg2+ were tested in each hypoxic, normoxic and hyperoxic states. Once the desired physical state was achieved, Mg2+ was administered at a dose of 100 mg/kg approximately every 10 min. In order to determine the exact mechanism of the Mg2+, Nw-nitro-l-arginine (LNNA), a NO synthase-inhibitor, was administered simultaneously with Mg2+ in some of the experiments. RESULTS: There was a significant correlation between the percent reduction of the pulmonary arterial pressure (PAP) caused by magnesium and the level of oxygen (O2) present in the pulmonary artery. The greatest amount of reduction was seen in the hypoxic condition where the least amount of O2 is found. A further reduction in the PAP was seen when NO was given at the end of the Mg2+ trials. There was no significant reduction seen in the systemic arterial pressure. CONCLUSIONS: Inhaled NO further reduced the PAP in piglets already treated with Mg2+.
  • |Animals[MESH]
  • |Animals, Newborn[MESH]
  • |Blood Pressure/drug effects[MESH]
  • |Calcium Channel Blockers/*therapeutic use[MESH]
  • |Drug Therapy, Combination[MESH]
  • |Hypertension, Pulmonary/*drug therapy/etiology[MESH]
  • |Hypoxia/complications[MESH]
  • |Linear Models[MESH]
  • |Magnesium Sulfate/*therapeutic use[MESH]
  • |Nitric Oxide/*therapeutic use[MESH]
  • |Pulmonary Artery/drug effects/physiopathology[MESH]
  • |Swine[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box